Bill Snyder

Insulin in vials
October 20, 2022

Aging beta cells hasten Type 2 diabetes

Vanderbilt investigators have found that aging induces chronic cellular stress in pancreatic beta cells, which could contribute to the development of diabetes as we age.

By Bill Snyder
Meena Madhur, MD, PhD, Matthew Alexander, MD, PhD, and colleagues are studying how a common genetic change impacts the development of inflammation and high blood pressure.
October 20, 2022

Study sheds light on the development of inflammation, high blood pressure and resulting kidney damage

By Bill Snyder
October 17, 2022

Three Vanderbilt faculty elected to the National Academy of Medicine

Three Vanderbilt University faculty members have been elected this year to membership in the National Academy of Medicine, a prestigious, non-governmental organization that advises the nation and the world on important aspects of medical science, health care and public health.

By Bill Snyder and Kiya Gaskin
Jeff Balser, MD, PhD, addresses members of the Quinq Society being honored at Vanderbilt University School of Medicine’s Reunion Weekend.
October 13, 2022

Jahangir shares COVID lessons at Reunion Weekend

By Bill Snyder
October 13, 2022

Gaudet set to deliver Elam Memorial Lecture Oct. 26

Patient-centered health care expert Tracy Gaudet, MD, will deliver the third annual Dr. Roy O. Elam Memorial Lecture Oct. 26 at noon in 214 Light Hall.

By Bill Snyder
The study found that increasing number of steps taken each day can steps taken daily can reduce the risk of several common, chronic diseases. (istock image)
October 10, 2022

Counting steps can reduce disease risk: study

A Vanderbilt study found that using a wearable activity tracker to count and increase the number and intensity of steps taken daily can reduce the risk of several common, chronic diseases.

By Bill Snyder
October 10, 2022

Opening a window to glaucoma

A metalloprotease enzyme plays an important role in retinal ganglion cell development, Vanderbilt researchers discovered; studying it and other family members may lead to the identification of novel targets for treating glaucoma.
By Bill Snyder
October 6, 2022

Vanderbilt’s Crowe receives the Building the Foundation Award from Research!America

Vanderbilt's James Crowe Jr., MD, has received the Building the Foundation Award from Research!America, a national biomedical research advocacy organization.
By Bill Snyder
October 6, 2022

VUMC to test whether Alzheimer’s drug can ease lupus symptoms

Vanderbilt University Medical Center is partnering with Evergreen Therapeutics Inc. to test whether an Alzheimer’s drug, memantine, can improve cognitive symptoms associated with systemic lupus.
By Bill Snyder
October 4, 2022

Vanderbilt’s Terker wins NIH Director’s Early Independence Award

Andrew Terker, MD, PhD, a physician-scientist at Vanderbilt University Medical Center who is committed to advancing the understanding and treatment of kidney disease, has received a 2022 National Institutes of Health Director’s Early Independence Award.
By Bill Snyder
September 29, 2022

VUMC lands grant to build top-line biosafety facility

Vanderbilt University Medical Center is set to construct a state-of-the-art BioSafety Level 3 (BSL3) facility for research involving the COVID-19 virus, anthrax and other dangerous microorganisms.
By Bill Snyder
September 29, 2022

Vanderbilt Translational Research Forum set for Oct. 21

Vanderbilt Translational Research Forum, an annual celebration of the “translation” of scientific discovery into clinical practice, will be held Oct. 21 at the Vanderbilt University Student Life Center.
By Bill Snyder